Drug Shortage Report for CLINIMIX
| Report ID | 147032 |
| Drug Identification Number | 02046709 |
| Brand name | CLINIMIX |
| Common or Proper name | CLINIMIX 5% Amino Acids (Blend B) in 16.6% Dextrose Injection |
| Company Name | BAXTER CORPORATION |
| Market Status | MARKETED |
| Active Ingredient(s) | L-ISOLEUCINE L-LYSINE METHIONINE L-PHENYLALANINE HYDROCHLORIDE L-LEUCINE HYDROCHLORIDE DEXTROSE L-TYROSINE L-PROLINE L-ARGININE GLYCINE L-ALANINE TRYPTOPHAN L-THREONINE HISTIDINE L-VALINE |
| Strength(s) | 240MG 290MG 290MG 310MG 310MG 16.6G 20MG 210MG 520MG 1040MG 1040MG 90MG 210MG 220MG 230MG |
| Dosage form(s) | LIQUID |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 1000mL (JB6770P) |
| ATC code | B05BA |
| ATC description | I.V. SOLUTIONS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2021-10-13 |
| Actual start date | 2021-10-13 |
| Estimated end date | 2021-10-21 |
| Actual end date | 2021-10-21 |
| Shortage status | Resolved |
| Updated date | 2021-10-25 |
| Company comments | Baxter is experiencing a delay in raw materials which has resulted in a supply disruption on certain CLINIMIX and TRAVASOL products. Impacted products have been placed on allocation. The supply issue is expected to be resolved in early October. Contact your Baxter sales rep or Baxter customer service for list of available CLINIMIX products which remain available to order. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 7125 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 0C2 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2021-10-25 | French | Compare |
| v4 | 2021-10-25 | English | Compare |
| v3 | 2021-10-14 | English | Compare |
| v2 | 2021-10-13 | French | Compare |
| v1 | 2021-10-13 | English | Compare |
Showing 1 to 5 of 5